An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …

The heterogeneous nature of myelodysplastic syndromes (MDS) demands a complex and
personalized variety of therapeutic approaches. Among them, allogeneic hematopoietic …

Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet,
an Expert Panel was selected according to the framework elements of the National Institutes …

This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …

Purpose Age has long been used as a major factor for assessing suitability for allogeneic
hematopoietic cell transplantation (HCT). The HCT-comorbidity index (HCT-CI) was …

Objectives: Describe the indications for hematopoietic stem cell transplants. Review the
contraindications to hematopoietic stem cell transplants. Outline the potential complications …

Allogeneic haematopoietic stem-cell transplantation (HSCT) is frequently applied as part of
the treatment in patients with acute myeloid leukaemia (AML) in their first or subsequent …

Killer-cell immunoglobulin-like receptor (KIR) genes form a diverse, immunogenetic system.
Group A and B KIR haplotypes have distinctive centromeric (Cen) and telomeric (Tel) gene …

The use of posttransplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD)
prophylaxis has revolutionized haploidentical hematopoietic stem cell transplantation …

Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by
ineffective haemopoiesis leading to blood cytopenias, and by progression to acute myeloid …